| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |